Vium, founded in 2013 and headquartered in the United States, is pioneering a transformation in preclinical research with its slogan, "Creating digital biomarkers to transform preclinical research and animal welfare." The company stands at the forefront of innovation with the Vium Digital Vivarium™, a platform that integrates Vium Smart Housing™, a robust cloud infrastructure, and their intuitive online Research Suite. This offering optimizes the utilization of bioengineered research models in unprecedented ways.
Vium is positioned at the intersection of Biotechnology, Health Care, Life Sciences, and Medical Devices, serving a broad clientele ranging from biotechnology firms to academic labs. Notably, the company has earned accreditation by AAALAC International with a commendation for its adherence to humane research practices.
The firm secured a $24.00M Series B investment on June 21, 2018 from prominent backers including Founders Fund, Lux Capital, DCVC, Dolby Ventures, and Future Shape, underscoring robust investor confidence in its potential to revolutionize drug research.